CIK 0001175680
- Non-accelerated filer
- Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753056237
- Phone
- +1 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- 4 Grant or award CMO acquired 6,950 shares (grant or award)
- 4 Grant or award CFO acquired 5,208 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 7,102 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 5,614 shares (grant or award)
- 4 Grant or award CMO acquired 7,492 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Technology Officer acquired 12,428 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 9,824 shares (grant or award)
- 4 Grant or award CMO acquired 13,112 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 13,020 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 10,292 shares (grant or award)
- 4 Grant or award CMO acquired 13,736 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 13,671 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 10,807 shares (grant or award)
- 4 Grant or award CMO acquired 14,423 shares (grant or award)
- 4 Grant or award CMO acquired 89,985 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 85,296 shares (grant or award)
- 4 Grant or award Recknor Chris P acquired 30,696 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 67,425 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 4 of 22 · 435 filings